Diabetic Peripheral Neuropathic Pain Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Evaluate the Effectiveness and Safety of Spray YJ001 in the Treatment of Diabetic Peripheral Neuropathic Pain.
In this study, a randomized, double-blind, placebo parallel-controlled design was used to evaluate the effectiveness and safety of YJ001 spray applied to local skin in patients with diabetic peripheral neuropathic pain, and to explore the best effective dose.
In this study, a randomized, double-blind, placebo parallel-controlled design was used to evaluate the effectiveness and safety of YJ001 spray applied to local skin in patients with diabetic peripheral neuropathic pain, and to explore the best effective dose. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04094662 -
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain
|
Phase 3 | |
| Not yet recruiting |
NCT06054087 -
Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy
|
N/A | |
| Not yet recruiting |
NCT05292066 -
Efficacy of Pregabalin Vs Duloxetine in Diabetic Peripheral Neuropathic Pain at Variable Dose
|
Early Phase 1 | |
| Completed |
NCT04688671 -
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
| Recruiting |
NCT06203002 -
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
|
Phase 2 | |
| Completed |
NCT05620576 -
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05)
|
Phase 2 | |
| Completed |
NCT04146896 -
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
|
Phase 2 | |
| Recruiting |
NCT05521737 -
Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy
|
N/A | |
| Terminated |
NCT04707157 -
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
| Terminated |
NCT02156336 -
Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
|
Phase 4 | |
| Recruiting |
NCT06122012 -
To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China
|
N/A | |
| Recruiting |
NCT06221241 -
Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT01314222 -
Diabetic Peripheral Neuropathic Pain (DPNP)
|
Phase 2 | |
| Completed |
NCT00829387 -
Cognitive Behavioral Therapy for Diabetic Neuropathic Pain
|
N/A | |
| Not yet recruiting |
NCT05766969 -
Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA
|
Phase 1/Phase 2 | |
| Completed |
NCT05349357 -
Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy
|
N/A | |
| Completed |
NCT03909841 -
Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition
|
||
| Completed |
NCT04476108 -
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT05177094 -
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
|
Phase 2 | |
| Completed |
NCT02318706 -
DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain
|
Phase 3 |